City
Epaper

Covid provides long-lasting natural immunity, says large Lancet study

By IANS | Updated: February 17, 2023 16:25 IST

New Delhi, Feb 17 For people who have been infected with Covid-19 at least once before, natural immunity ...

Open in App

New Delhi, Feb 17 For people who have been infected with Covid-19 at least once before, natural immunity against severe disease (hospitalisation and death) was strong and long-lasting for all variants (88 per cent or greater at 10 months post infection), a largest review and meta-analysis published in The Lancet has revealed.

Past infection with pre-Omicron variants provided substantially reduced natural immunity protection against reinfection with Omicron BA.1 (36 per cent at 10 months after infection).

The researchers said we should recognise the natural immunity in people who have recently been infected with Covid-19, but warn that their findings should not discourage vaccination because it is the safest way to acquire immunity.

For someone previously infected with Covid-19, their risk of hospitalization or death is 88 per cent lower for at least 10 months compared to those who had not been previously infected, according to a systematic review and meta-analysis.

The analysis also suggests that the level and duration of protection against reinfection, symptomatic disease and severe illness is at least on a par with that provided by two doses of the mRNA vaccines (Moderna, Pfizer-BioNtech) for ancestral, Alpha, Delta and Omicron BA.1 variants.

The study did not include data on infection from Omicron XBB and its sub-lineages.

"Vaccination is the safest way to acquire immunity, whereas acquiring natural immunity must be weighed against the risks of severe illness and death associated with the initial infection," says lead author Dr Stephen Lim from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington's School of Medicine.

The review and meta-analysis included 65 studies from 19 countries.

"Vaccines continue to be important for everyone in order to protect high-risk populations such as those who are over 60 years of age and those with comorbidities," said IHME co-author Dr Caroline Stein.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: DeltaThe lancet infectious diseasesThe lancet public healthThe lancetThe lancet planetary healthThe lancet oncologyThe lancet psychiatryThe lancet neurologyThe lancet global healthThe lancet diabetes and endocrinology
Open in App

Related Stories

NationalAadi Festival: Tamil Nadu Govt Steps Up Vigil in Delta Districts After Mettur Dam Opens

InternationalDiabetics must focus on preventing complications: Top diabetologist

HealthHalf of tuberculosis cases in prisons worldwide go unnoticed: Study

InternationalDelta airlines flight diverted in US due to unruly passenger

HealthGlobal diabetes cases to soar to 1.3 billion by 2050: Lancet

Health Realted Stories

HealthCentre extends financial aid to indigenous indoor air purification solution

HealthChildhood exposure to bacterial toxin can trigger Colorectal cancer among the young: Study

HealthIndia achieves breakthrough in gene therapy for haemophilia: Minister

LifestyleWalking Tips for Summer: Know the Best time to Walk to Avoid Heatstroke

HealthCentre launches campaign to achieve 100 pc Measles-Rubella immunisation coverage